One year after neffy's approval, 4 clinicians and 1 PharmD examine its continuing impact on the field.
Matthew Greenhawt, MD, MBA, MSc
Advertisement
Matthew Greenhawt, MD, MBA, MSc, CMO of Asthma and Allergy Foundation of America (AAFA), former professor at Childrens' Hospital Colorado and University of Colorado
Articles by Matthew Greenhawt, MD, MBA, MSc
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Prevalence and Recognition of Hypercortisolism
2
Screening and Diagnosis of Hypercortisolism in Type 2 Diabetes
3
Skin of Color Savvy—A New Generation of Dermatology Leadership, With Umayr Shaikh, MPH
4
Distinguishing CSU From Chronic Inducible Urticaria Subtypes
5